TSC2致病变异可能通过激活mTOR诱导原始卵泡过度活化导致早发性卵巢功能不全
在1030例特发性早发性卵巢功能不全(POI)患者的全外显子测序队列中,6例患者检出5个TSC2致病性杂合变异;功能研究显示这些变异破坏TSC复合物形成或GTP酶激活蛋白活性,减弱TSC2对mTOR通路的抑制,体外卵巢培养中TSC2 p.R98Q导致mTOR通路过度活化并触发原始卵泡活化。
要点
- 1030例特发性POI患者中6例检出5个TSC2致病性杂合变异。
- TSC2变异通过破坏TSC复合物或GTP酶激活蛋白活性减弱对mTOR通路的抑制。
- 体外卵巢培养中TSC2 p.R98Q导致mTOR通路过度活化并触发原始卵泡活化。
核心结论
- 本研究在POI患者中鉴定出TSC2致病变异,首次提示缺陷的TSC/mTOR通路介导的原始卵泡过度活化参与POI发病,为POI遗传咨询和临床预防提供新靶点。
- 鉴于TSC2变异在TSC综合征诊断中的关键作用,本研究也强调对TSC2变异携带者进行病史采集和长期随访的重要性。
研究设计与样本
- 遗传与功能研究,在大学附属生殖医学中心开展。
- 研究对象为1030例特发性POI队列中的6例患者。
- 通过1030例特发性POI患者的最大院内全外显子测序数据库筛查TSC1和TSC2变异,并用功能研究验证变异的致病效应。
主要发现
- 在6例POI患者中鉴定出5个TSC2致病性杂合变异。
- 功能研究显示这些变异通过破坏TSC复合物形成或其GTP酶激活蛋白活性,削弱TSC2对哺乳动物雷帕霉素靶蛋白(mTOR)通路的抑制作用。
- 体外卵巢培养实验显示TSC2 p.R98Q导致mTOR通路过度活化,从而触发原始卵泡活化。
关键数值与推荐
- 在1030例特发性POI患者中检出6例携带TSC2致病变异。
- 共鉴定出5个TSC2致病性杂合变异。
- TSC2 p.R98Q在体外卵巢培养中导致mTOR通路过度活化并触发原始卵泡活化。
临床怎么用
- 作者认为本研究为POI的遗传咨询和临床预防提供了新靶点。
- 作者强调鉴于TSC2变异在TSC综合征诊断中的关键作用,应对TSC2变异携带者重视病史采集和长期随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the role of tuberous sclerosis complex (TSC) genes, including TSC1 and TSC2, in the pathogenesis of human premature ovarian insufficiency (POI). DESIGN: Genetic and functional study. SETTING: University-based reproductive medical center. PATIENT(S): Six patients from a cohort of 1,030 cases with idiopathic POI. INTERVENTION(S): Variants in TSC1 and TSC2 were screened through the largest in-house database of whole exome sequencing performed in 1,030 patients with idiopathic POI. The pathogenic effects of the variants were further verified by functional studies. MAIN OUTCOME MEASURE(S): TSC1 or TSC2 variant and functional characteristics. RESULT(S): Five pathogenic heterozygous variants in TSC2 were identified in 6 patients with POI. Functional studies showed these variants impaired the repressive effect of TSC2 on mammalian target of rapamycin (mTOR) pathway by disrupting the formation of TSC complex or its GTPase-activating protein activity. Furthermore, in vitro ovarian culture assay showed that TSC2 p.R98Q led to hyperactivation of mTOR pathway thereby triggering primordial follicle activation. CONCLUSION(S): The present study identified pathogenic variants of TSC2 in patients with POI, firstly suggested defective TSC/mTOR pathway mediated hyperactivation of primordial follicle participating in the pathogenesis of POI, giving insights into new targets of genetic counseling and clinical prevention for POI. Considering the pivotal role of TSC2 variants in diagnosis of TSC syndrome, the present study also highlighted the importance of history collection and long-term follow-up for the TSC2 variants carriers.
引用
- Xu B, Li Z, Li S, et al. Pathogenic variants in TSC2 might cause premature ovarian insufficiency through activated mTOR induced hyperactivation of primordial follicles. Fertil Steril. 2022. PMID: 36229297. doi:10.1016/j.fertnstert.2022.08.853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。